Agenus, Inc. (AGEN)
3.89
-0.28
(-6.71%)
USD |
NASDAQ |
May 06, 16:00
3.89
0.00 (0.00%)
Pre-Market: 20:00
Agenus Free Cash Flow : -77.20M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Inovio Pharmaceuticals, Inc. | -88.92M |
| The Ensign Group, Inc. | 406.10M |
| Protalix Biotherapeutics, Inc. | -13.63M |
| CervoMed, Inc. | -23.45M |
| Allogene Therapeutics, Inc. | -149.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.62M |
| Cash from Investing (Quarterly) | 0.78M |
| Cash from Financing (Quarterly) | 15.37M |
| Free Cash Flow Per Share (Quarterly) | -0.4705 |
| Free Cash Flow to Equity (Quarterly) | -10.57M |
| Free Cash Flow to Firm (Quarterly) | -0.569M |
| Free Cash Flow Yield | -65.73% |